Live Breaking News & Updates on Vincerx Pharma Inc
Stay updated with breaking news from Vincerx pharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vincerx Pharma, Inc. (NASDAQ:VINC – Get Free Report) saw a significant decrease in short interest in May. As of May 15th, there was short interest totalling 567,500 shares, a decrease of 44.9% from the April 30th total of 1,030,000 shares. Based on an average trading volume of 927,300 shares, the short-interest ratio is presently 0.6 […] ....
Vincerx Pharma, Inc. (NASDAQ:VINC – Get Free Report) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 567,500 shares, a decline of 44.9% from the April 30th total of 1,030,000 shares. Based on an average daily volume of 927,300 shares, […] ....
Vincerx Pharma (NASDAQ:VINC) Announces Earnings Results theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Immune Therapeutics (OTCMKTS:IMUN – Get Free Report) and Vincerx Pharma (NASDAQ:VINC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, valuation, dividends and risk. Earnings & Valuation This table compares Immune […] ....